#COVID-19 Impacts On Diabetic Retinopathy Market

[market-insider]

Diabetic Retinopathy Market Update: Emerging Technologies and Innovations

Diabetic retinopathy is a serious eye condition that occurs as a complication of diabetes. It specifically affects the retina, which is the light-sensitive tissue lining the back of the eye. High blood sugar levels over an extended period of time can damage the small blood vessels within the retina, leading to various changes and abnormalities. There are two main types of diabetic retinopathy: non-proliferative and proliferative. Non-proliferative diabetic retinopathy is the early stage of the condition, where the blood vessels in the retina leak fluid and blood, causing swelling and the formation of small deposits called exudates. This stage may not exhibit noticeable symptoms, but regular eye examinations can detect these changes. Proliferative diabetic retinopathy is the advanced stage of the disease. In this stage, the damaged blood vessels of the retina prompt the growth of new, abnormal blood vessels. These new vessels are fragile and prone to bleeding, which can lead to the formation of scar tissue. As the disease progresses, the scar tissue can contract and pull on the retina, causing it to detach and resulting in severe vision loss or blindness if not treated promptly. Diabetic retinopathy commonly affects both eyes, and individuals with diabetes are at a higher risk of developing this condition. Factors that contribute to its development include the duration of diabetes, poorly controlled blood sugar levels, high blood pressure, high cholesterol, and pregnancy. Treatment options depend on the stage of the disease and may include laser therapy to seal leaking blood vessels, injections of medications to reduce abnormal blood vessel growth, and surgery in advanced cases. Additionally, effective management of diabetes through proper blood sugar control, blood pressure management, and healthy lifestyle choices can help prevent or slow the progression of diabetic retinopathy.

Gain deeper insights on the market and receive your free copy with TOC now @: Diabetic Retinopathy Market Report

The Diabetic Retinopathy market has witnessed advancements in diagnostic technologies, such as retinal imaging and optical coherence tomography (OCT). These technologies enable earlier and more accurate detection of retinal changes associated with diabetic retinopathy, facilitating timely intervention and treatment. Research and development efforts have focused on developing new pharmacological treatments for diabetic retinopathy. Anti-vascular endothelial growth factor (VEGF) drugs, such as ranibizumab and aflibercept, have shown efficacy in reducing abnormal blood vessel growth and improving vision in patients with diabetic macular edema, a complication of diabetic retinopathy. AI and machine learning technologies are being increasingly explored in the field of diabetic retinopathy. These technologies can analyze retinal images and OCT scans to detect and classify diabetic retinopathy, aiding in early diagnosis and monitoring of the disease. AI-based screening tools have the potential to improve access to diabetic retinopathy screening in underserved areas and streamline the detection process. Telemedicine and remote monitoring platforms have gained prominence, particularly during the COVID-19 pandemic. These platforms allow healthcare professionals to remotely assess and monitor patients with diabetic retinopathy, reducing the need for in-person visits and improving patient convenience and access to care. There is growing interest in personalized medicine approaches for diabetic retinopathy. Genetic profiling and biomarker identification may help predict an individual's risk for developing diabetic retinopathy or its progression, enabling targeted interventions and treatments based on the patient's specific profile. Various stakeholders, including pharmaceutical companies, technology providers, research institutions, and healthcare organizations, are collaborating to advance the field of diabetic retinopathy. Collaborative efforts aim to improve understanding, develop innovative solutions, and enhance patient outcomes through a multidisciplinary approach.

[industryforecastnews]

Ophthalmic Devices Market Size To Reach $9.79 Billion By 2030 | CAGR of 4.92%

Ophthalmic Devices Market Growth & Trends

The global ophthalmic devices market size is anticipated to reach USD 9.79 billion by 2030, registering a CAGR of 4.92% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising geriatric population is presumed to propel the need for ophthalmic devices due to the high risk of developing chronic eye disorders. According to the National Institute on Aging (NIA), the geriatric population will be about 72 million individuals by 2030. The rising prevalence of eye disorders, such as macular degeneration, cataracts, diabetic retinopathy, and glaucoma, is also boosting product demand. As per the WHO, glaucoma accounts for 4.5 million cases of blindness globally. In the United States, glaucoma is termed the "Silent Thief of Sight," which is the second-leading cause of blindness.

The market growth can also be attributed to technological advancements, such as the development of intraocular lenses, fundus cameras, and OCT devices. Furthermore, the increasing involvement of market players in expanding treatment solutions through strategic alliances is expected to present this market with a potential growth platform. Approximately 10% of the people suffering from eye disorders are expected to experience loss of vision despite the proper treatment, as per the statistics of the WHO, driving the clinical urgency to incorporate highly advanced ophthalmic devices. Furthermore, rising demand for minimally invasive and complication-free operative surgeries is expected to boost product demand. Due to the COVID-19 pandemic, the majority of the population's screen time was increased, resulting in increased cases of various eye issues, which will support market growth over the forecast period.

The growing geriatric population is increasing the demand for ophthalmic devices, as they are more susceptible to age-related ophthalmic disorders. According to the National Institute on Aging (NIA), the geriatric population is expected to reach around 72 million by 2030. The increasing prevalence of diabetes and the incidence of diabetes-related blindness are predicted to fuel market growth. According to the World Health Organization, nearly 422 million people worldwide have diabetes, and the majority are living in low- and middle-income countries.

Increased screen time due to the lockdown measures in the COVID-19 pandemic has been associated with the onset and progression of various eye diseases, thus driving the demand for eye examinations. In June 2020, Johnson & Johnson Vision donated USD 320,000 to provide eye care to COVID-19-impacted patients. The organization conducted this donation to the Optometry Cares unit of the American Optometric Association (AOA) Foundation and the American Academy of Optometry Foundation (AAOF).

Request a free sample copy or view report summary: Ophthalmic Devices Market Report

Ophthalmic Devices Market Report Highlights

Based on product, the optical coherence tomography scanners (OCT) segment dominated the global market in 2023

The segment accounted for the largest share of over 23% of the overall revenue in 2023, which can be attributed to its wide range of applications

The ophthalmoscopes segment is expected to witness significant growth from 2024 to 2030 on account of technological advancements

The cataract application segment accounted for the largest revenue share in 2023 and is expected to continue its dominance over the forecast period

This growth can be attributed to the increasing number of patients suffering from cataracts and high product adoption for cataract surgeries

Regional Insights

North America held the largest share in 2023. A high population of older adults and rising prevalence of chronic eye conditions resulting from factors, such as high stress and unhealthy lifestyles; ultimately leading to diabetic retinopathy, are considered high-impact rendering drivers for the market. In addition, the incorporation of new reimbursement models for ophthalmologic treatment and a stringent regulatory framework aimed at patients’ safety, is expected to fuel product demand in this region.

The U.S. possesses a well-developed healthcare system with leading academic institutions and research facilities. This encourages innovations in ophthalmic devices in terms of minimally invasive surgical techniques, advanced diagnostic instruments, and personalized medicine approaches, thereby propelling growth for the U.S. market. The U.S. spends significantly on healthcare compared to other developed countries, with total healthcare spending projected to reach $4.8 trillion by 2030. This translates into increased funding for specialized therapies and devices, including eye care.

Ophthalmic Devices Market Segmentation

Grand View Research has segmented the global ophthalmic devices market based on product, application, end-use, and region:

Ophthalmic Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

Optical Coherence Tomography Scanners

Fundus Cameras

Perimeters/Visual Field Analysers

Autorefractors and Keratometers

Ophthalmic Ultrasound Imaging Systems

Ophthalmic A-Scan Ultrasound

Ophthalmic B-Scan Ultrasound

Ophthalmic Ultrasound Biomicroscopes

Ophthalmic Pachymeters

Tonometers

Slit Lamps

Phoropters

Wavefront Aberrometers

Optical Biometry Systems

Ophthalmoscopes

Lensmeters

Corneal Topography Systems

Specular Microscopes

Retinoscopes

Ophthalmic Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

Cataract

Vitreo Retinal Disorders

Glaucoma

Refractor Disorders

Ophthalmic Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals & Eye Clinics

Academic & Research Laboratory

Others

Ophthalmic Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

U.K.

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Brazil

Mexico

Argentina

Colombia

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in Ophthalmic Devices Market

Johnson & Johnson Vision Care

Alcon Vision LLC

Carl Zeiss Meditec AG

Bausch & Lomb Inc.

Essilor International S.A.

Ziemer Ophthalmic Systems Ltd.

Nidek Co. Ltd.

TOPCON Corporation

Haag-Streit Group

Browse Full Report: Ophthalmic Devices Market Report

[jayanthitbrc]

Navigating Growth Trajectories: In-Depth Optical Coherence Tomography Market Size Analysis, Share and Future Trends

  Overview and Scope Optical coherence tomography (OCT) is an optical biopsy and effective imaging technology for medical diagnostics that provides images of tissue in situ and in real-time. Optical coherence tomography is used for high-resolution cross-sectional imaging. Sizing and Forecast The optical coherence tomography market size has grown rapidly in recent years. It will grow from $1.72 billion in 2023 to $1.94 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%.  The optical coherence tomography market size is expected to see rapid growth in the next few years. It will grow to $3.17 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%.  To access more details regarding this report, visit the link: https://www.thebusinessresearchcompany.com/report/optical-coherence-tomography-global-market-report Segmentation & Regional Insights The optical coherence tomography market covered in this report is segmented – 1) By Type: Catheter-Based OCT Devices, Doppler OCT Devices, Handheld OCT Devices, Tabletop OCT Devices   2) By Technology: Time Domain OCT (TDOCT), Frequency Domain OCT (FD-OCT), Spatial Encoded Frequency Domain OCT 3) By Application: Ophthalmology, Cardiovascular, Oncology, Dermatology, Other Applications North America was the largest region in the optical coherence tomography market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical coherence tomography market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Intrigued to explore the contents? Secure your hands-on sample copy of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=8231&type=smp Major Driver Impacting Market Growth The rising prevalence of eye disorders is expected to support the growth of the optical coherence tomography market. Globally, eye conditions, including cataract, glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD) are leading causes of vision loss and blindness. The demand for advanced disease diagnostic tools like optical coherence tomography systems is growing due to the rise in eye ailments. Key Industry Players Major companies operating in the optical coherence tomography market report are Agfa-Gevaert N.V., Carl Zeiss Meditec AG, Heidelberg Engineering GmbH, Imalux Corporation, Michelson Diagnostics Limited, Novacam Technologies Inc., OPTOPOL Technology Sp. z o.o. The optical coherence tomography market report table of contents includes: 1. Executive Summary 2. Market Characteristics 3. Market Trends And Strategies 4. Impact Of COVID-19 5. Market Size And Growth 6. Segmentation 7. Regional And Country Analysis . . . 27. Competitive Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[anyawinget]

Middle East and Africa Vitrectomy Devices Market Competitive Analysis Based On Types, Application And Precise Outlook 2021

The Middle East and Africa Vitrectomy Devices Market report offers insights into the newest growth and trends. It summarizes crucial aspects of the market, with a target on leading key player areas that have witnessed the highest demand, leading regions, and operations. The Middle East and Africa Vitrectomy Devices market offers qualitative as well as quantitative information data relating to the factors, challenges, and opportunities that may define the expansion of the market over the forecast period. The report aims to supply a further illustration of the newest scenario, economic slowdown, and COVID-19 impact on the overall industry. Get a Sample PDF Copy:

https://www.businessmarketinsights.com/sample/TIPRE00026821

Top Key Players Listed in the Middle East and Africa Vitrectomy Devices Market Report Are:

· D.O.R.C Dutch Ophthalmic Research Center (International)B. V

· HOYA Corporation

· Danaher (Leica Microsystems AG)

· Carl Zeiss Meditec

· Alcon Inc.

· Bausch Health Companies Inc.

· Topcon Corporation

In this report, the market has been segmented on the basis of:

Based on types, the Middle East and Africa Vitrectomy Devices market is primarily split into:

· Vitrectomy Machines

· Vitrectomy Accessories

· Microscopic Illumination Equipment

· Surgical Instruments

· Others

Based on Applications the Middle East and Africa Vitrectomy Devices market covers:

· Diabetic Retinopathy

· Retinal Detachment

· Epiretinal Membrane

· Macular Hole

· Others

The Middle East and Africa Vitrectomy Devices Market Competitive Viewpoint:

This analysis is a useful resource for investors, shareholders, industry planners, and new and existing businesses trying to broaden their reach within the current Market situation. While focusing on top companies and their corporate strategies, market presence, operative segmentation, aggressive outlook, geographical growth, pricing, and price structures, the study painstakingly takes into consideration the market analysis.

Key Features of the Report and Middle East and Africa Vitrectomy Devices Market Highlights:

-Comprehensive assessment of all opportunities and risks in the regional market.

-Middle East and Africa Vitrectomy Devices market recent innovations and major events.

-Detailed study of business strategies for growth of the Middle East and Africa Vitrectomy Devices market-leading players.

-Conclusive study about the growth plot of the Middle East and Africa Vitrectomy Devices market for forthcoming years.

-In-depth understanding of the Middle East and Africa Vitrectomy Devices market -particular drivers, constraints, and major micro-Markets.

-Favorable impression inside vital technological and market latest trends striking the Middle East and Africa Vitrectomy Devices

Click Here to Buy Now:

https://www.businessmarketinsights.com/buy/single/TIPRE00026821

Reason to buy this report:

-Understand the Current and future of the Middle East and Africa Vitrectomy Devices Market in both Established and rising markets.

-The report enlightens the massive patterns, causes, and impact factors globally and regionally.

-The latest developments within the Middle East and Africa Vitrectomy Devices market and details of the industry leaders alongside their market share and methods.

-It looks into vital developments like extensions, agreements, new product launches, and acquisitions on the horizon.

-Analysis of the market’s potential, preferred position, opportunity, difficulty, restrictions, and hazards on a world and regional level.

*Customized Analysis report: We offer clients specialized report services that take into consideration the most variables influencing the development of the worldwide Market. Feel free to call or drop your requirement to get the get customized research report.

About Us:

Business Market Insights is a market research platform that provides subscription services for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Contact Us:

If you have any questions about this report or would like further information, please contact us:

Contact person: Ankit Mathur

Phone: +16467917070

Email: sales@businessmarketinsights.com

[esglatestmarketnews]

U.S. Ophthalmic Devices—a Deep-dive on the Patient Population based on Gender and Age Groups

The burgeoning aging population and a surge in obesity & diabetic cases have put the spotlight on advanced ophthalmic devices. The National Institute on Aging (NIA) estimates the geriatric population to reach 72 million by 2030, while the WHO suggests around 422 million people are living with diabetes. These trends imply the prevalence of vision impairment and blindness due to diabetic retinopathy, cataracts, glaucoma, age-related macular degeneration and vitreo-retinal disorders. Besides, the onset of the COVID-19 outbreak led to increased screen time, spurring the demand for eye examinations. 

Grand View Research has aptly paid heed to the evolving customer preferences and the paradigm shift witnessed in the healthcare & medical space. The final report, along with the database, will deliberate upon the following industry dynamics:

The demand for minimally invasive surgeries, including multi-wavelength diabetic retinopathy treatment and LASIK surgery.

Trend for ophthalmic devices across hospitals and eye clinics. 

Early detection and treatment of eye diseases to help prevent vision loss. 

Significance of adults receiving eye exams: The American Academy of Ophthalmology mentions that over 22 million adults grapple with vision impairment, and 61 million U.S. adults are at a high risk of vision loss. 

The influence of AI as well as the impact of campaigns and programs.

Get your copy or request for a free sample of the report “U.S. Ophthalmic Patient Population Statistics Study Report”, compiled and published by Grand View Research.

Attribute

U.S. Ophthalmic Patient Population (2022)

Age Groups

Gender

Glass Vs Contact Lenses

Single Vision Vs Multifocal

Number of LASIK surgeries

Ethnicity

Population wearing glasses

% of people that wear glasses for Single Vision Vs Multifocal

Number of people wearing bifocal, trifocal, and progressive lenses

% of the population that has an oculus dexter and oculus sinister measurement between -6 and +6 in the prescription)

Get more insights from our in-depth market intelligence report “Ophthalmic Devices Market Analysis By Product (Optical Coherence Tomography, Ophthalmic Ultrasound), By Application (Cataract, Glaucoma), By End Use (Hospitals and Eye Clinics) And Segment Forecasts, 2022 – 2030.”

About Us Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Find More information @ https://www.grandviewresearch.com/info/trend-reports

[impossibledeanmakerwombat]

Vitrectomy Devices Market 2022 Growth, COVID Impact, Trends Analysis Report 2032

According to Future Market Insights’ newly released Vitrectomy Devices Market analysis report, According to a recently published industry study report by Future Market Insights, sales of vitrectomies devices were US$ 1.2 billion worldwide in 2021. The market is anticipated to grow at a CAGR of 7.3% from 2022 to 2032, reaching a worth of US$ 2.6 billion. The greatest revenue-generating kind is anticipated to be vitrectomy machines, with a nearly US$ 1.3 billion opportunity in absolute terms from 2022 to 2032. Request a Sample of this Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-16022

With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Vitrectomy Devices market.

FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Vitrectomy Devices market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision.

Over the past decade, healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.

The report offers extensive data sets validating key trends impacting growth in the Vitrectomy Devices market. It offers insights into strategies adopted by the key players rise and address the concerns that will challenge the growth of Vitrectomy Devices market. With our extensive research and information about the past, current and future market scenario, the Vitrectomy Devices market report will help and identify the concerns, for a smooth-sail of the small & medium as well as large enterprises.

Critical Questions Answered in the Report

What are ongoing trends that will shape market growth curve for global Vitrectomy Devices market? What are the drivers and challenges affecting the Vitrectomy Devices market demand? What are the recent technological advancement in the Vitrectomy Devices market? What are key trends and opportunities that will prevail the revenue growth of Vitrectomy Devices market players? How will evolving regulatory policies impact the market growth? What is the impact of Covid-19 on the Vitrectomy Devices market?

Ask the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-16022 Market Segments Covered in Vitrectomy Devices Industry Analysis

By Product Type:

Vitrectomy Machines Vitrectomy Packs Photocoagulation Lasers Illumination Devices

By Application:

Diabetic Retinopathy Retinal Detachment Macular Hole Vitreous Hemorrhage Other Applications

By End-use: Hospitals Ophthalmic Clinics Ambulatory Surgical Centres

Comprehensive analysis of the regional markets offers exclusive insights on the market performance across geographies along with relevant graphs, figures, and list of tables.Full Report @https://www.futuremarketinsights.com/reports/vitrectomy-devices-market

[alliecatcowboy]

Artificial Intelligence

Computers surround the world we live in, making it impossible to go your entire life without using a computer. Cars, ATMs, and TVs we use every day, and all contain computers. It is for this reason that computers and their software have to become more intelligent to make our lives easier and computers more accessible. Artificial intelligence, or AI, has the ability of a computer or machine to mimic the capabilities of the human mind. Which can vary from learning from examples and experience, recognizing objects, understanding and responding to language, making decisions, or problem-solving.

Just a few years after artificial intelligence was discovered, new inventions, such as the robot, were created. George Devol invented the first industrial robot named Unimate. Unimate was the first machine to do tasks too dangerous for humans, such as working on cars. To be specific it would transport die casting from the assembly line and weld parts onto other cars. This became a huge step forward in technology because humans were finally receiving assistants for things they were incapable of doing. 

Since the start of AI, it has made our lives easier and brung many positive social impacts along the way. For instance, during this whole Covid-19 outbreak, it has made datasets available for the researchers globally, which helps develop Covid-19 self-screening tools for the general public. It also prevents environmental challenges such as detecting forecasting floods quickly and accurately to prevent potential damage, predicting the risk of cardiac events, mapping global fishing activity, and more (TitleMax 2020 ). AI can even help make products like portable eye-scanning devices that are affordable, which makes a difference on a much larger scale. They do this by companies collaborating to detect retinal diseases such as diabetic retinopathy by creating a faster diagnosis. 

Economically, Artificial Intelligence increases the efficiency of creating products. For example, It improves the decision-making process by analyzing large amounts of data. New products and services, along with markets and industries, are boosted in consumer demand which generates high revenues because of AI. Artificial intelligence has the potential to incrementally add 16 percent or around $13 trillion by 2030 to current global economic output (Reynoso 2020). 

I am interested in AI because of how vast it is progressing. New discoveries are constantly being created daily. I definitely think this is the future of technology so it is interesting to learn more about. I would like to learn more about costs, more so if this is financially reasonable to adapt to everyone's day to day life.

[bhavesh2022]

Stevia Market is anticipated to Record a Valuation of US$ 965.82 million By 2028, a Recent Study By The Insight Partners

According to the latest market study on “Stevia Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type (Whole Leaf, Powder, and Liquid) and Application (Dairy and Frozen Dessert, Bakery and Confectionery, Tabletop Sweeteners, Beverages, and Others),” the market was valued at US$ 539.68 million in 2021 and is projected to reach US$ 965.82 million by 2028; it is expected to grow at a CAGR of 8.7% from 2021 to 2028.   The report highlights key driving factors and prominent market players along with their developments in the market.

The stevia plant is indigenous to tropical areas of Western North America and South America, including Paraguay and Brazil. The stevia plant's leaf extract is used as a natural sweetener with a number of health advantages, including reducing blood glucose and blood pressure levels. Stevia can be purchased in the market in three different forms: powder, liquid, and leaf, with the powder being composed of extremely sweet glycosides obtained from stevia leaves. One use for stevia is as a healthy, caloric-free sweetener.

The prevalence of diabetes and obesity is rising, and customers are gradually turning to natural sweetening goods. By 2040, the number of individuals with diabetes will increase from 415 million to 641 million, predicts the International Diabetes Foundation. Along with other chronic conditions like hypertension, metabolic syndrome, cardiovascular risk, and retinopathy, obesity is a common disease that increases the chance of developing diabetes. Authorities all around the world are putting an emphasis on leading a healthier lifestyle, which involves consuming fewer calories overall and notably fewer calories from added sugar. The World Health Organization (WHO) has advised against consuming as much added sugar as is currently being done. Customers prefer natural sweeteners like stevia to reduce their sugar intake, which aids in weight control by lowering added sugar and calories. Additionally, people in Europe are increasingly purchasing items without added sugar. Two-thirds of European consumers, according to the 2020 New Nutrition Business survey, are attempting to reduce their sugar intake as a result of the rise in obesity and diabetes, which has raised demand for stevia in Europe. The market for stevia is expanding as a result of consumers' growing preference for natural sweeteners.

Sugar consumption patterns and alternatives have been impacted by the current COVID-19 epidemic since there is less demand for sweeteners from beverage and other FMCG industries due to the lockdown in numerous countries. The food and beverage industry consumes the majority of stevia, and the lockdown in several countries, which has resulted in a shutdown of numerous industrial facilities, is expected to have an impact on consumption. Due to the COVID-19 epidemic, stores have shifted their stock priority toward essentials like staple foods and supplies, pushing back products like bakery goods, confectionary, dairy goods, and soft beverages that include food additives like sweeteners.

This was mostly brought about by the widespread lockdown orders issued by the governments of many nations in an effort to stop the virus from spreading within those nations. Due to the interruption in supply chains, lockdown and quarantine procedures as well as import and export restrictions enforced by states and governments are having an effect on the stevia exporters. Consumer preferences have undergone significant change as a result of the epidemic, which has raised awareness of the importance of leading a healthy lifestyle. Due to the pandemic, consumers are switching out traditional components for healthy ones, which is raising the demand for natural sweeteners like stevia. Demand has increased as a result of customers' rising dietary preferences for foods without added sugars and with few carbohydrates throughout the epidemic.

Cargill, Incorporated; Ingredion Incorporated; Tate & Lyle PLC; GLG LIFE TECH CORP; ADM; Sunwin Stevia International, Inc.; S&W Seed Company; Morita Kagaku Kogyo Co., Ltd.; Zhucheng Haotian Pharm Co., Ltd.; and PureCircle  are among well-established players in the global stevia market. Companies in the market are adopting strategies such as product developments, plant expansions, and mergers and acquisitions to expand their footprint worldwide and meet the growing demand from end users.

Based on type, the stevia market is segmented into whole leaf, powder, and liquid.  Based on application, the stevia market is segmented into dairy and frozen dessert, bakery and confectionery, tabletop sweeteners, beverages, and others. Geographically, the stevia market is segmented into five main regions—North America, Europe, Asia Pacific, Middle East and Africa, and South America.

Browse More Information@ https://www.theinsightpartners.com/reports/stevia-market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

[sanyuktak]

Wide Field Imaging Devices Market Revenue Growth, Qualitative Analysis, Quantitative Analysis Till 2029

Retinal imaging is a technique used for the generation of two-dimensional figures of the retinal tissue which is in three-dimensional (3D). These techniques are very indispensable for the management and the diagnosis of the disorder processes for practicing Ophthalmia and curing hypertensive retinopathy, diabetic retinopathy, macular degeneration related to the age, vascular pathologies, glaucoma, retinal detachments, leukemia, and systemic infections. The practitioners are ophthalmia is used to view the retinal disease and treatment planning based on the pathology.

COVID-19 scenario analysis:

To take care of the infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With a rise in the number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil populations for precautionary measures. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Owing to such factors, COVID 19 is expected to have a significant impact on the Wide field imaging devices market.

Widefield imaging devices are used for peripheral eye disorder diagnosis, peripheral eye tumor, and diabetic concerns. Once the process is done it is much easier for the image downloads and faster as compared to the alternative options which are the biggest factors propelling the growth of the wide field imaging devices market.

Upgrades in the technology in the field of telemedicine and portable camera development have betterment and the accessibility of these devices, and other new developments are expected to boost the wide-field imagine devices market. There has also been a boost in the frequency of diabetic retinopathy disorders and are resulting in the rise in demand for wide field imaging devices market.

Key Market Players

Heidelberg Engineering Inc.

Visunex Medical Systems, Inc

Carl Zeiss Meditec AG

Centervue S.P.A.

Clarity Medical Systems Inc.

Medibell Medical Vision Technologies Ltd.

Forus Health Pvt. Ltd

Docs Eye Care

Phoenix Technology Group, LLC

Epipole Ltd.

Key Advantages of the report:

·        The analytical depiction of the global Wide field imaging devices industry along with the current trends and future estimations to determine the imminent investment pockets.

·        Information related to key drivers, restraints, and opportunities along with detailed analysis of the global Wide field imaging devices market share.

·        The current market is quantitatively analyzed from 2020 to 2027 to highlight the global Wide field imaging devices market growth scenario.

·        Market analysis based on competitive intensity and how the competition will take shape in coming years.

[techtrendsgrowths]

Global Diabetic Retinopathy Market Size And Forecast : Analysis with key players

Zion Market Research recently released a study on the Global Diabetic Retinopathy Market Research Report Covers, Future Trends, Size, Share, Past, Present Data and Deep Analysis, And Forecast, 2022-2028 that includes a detailed analysis of major rivals, global revenue, key industry drivers, market segments, with their market shares. The report also carefully crafts the major areas and their countries to forecast regional and worldwide income. The impact of Covid-19 on the worldwide Diabetic Retinopathy market was also discussed in the paper. The statistical explanations in the form of graphs and tables will assist the user in gaining a comprehensive image of the market. In 2020, the global market is expected to be worth US$ xx Million, with a forecast of roughly US$ xx Million. The global market is predicted to grow at a CAGR of xx % from 2022 to 2028, according to estimates.

Request Access Full Report is Available @ https://www.zionmarketresearch.com/report/diabetic-retinopathy-market

Diabetic Retinopathy market Witness Most Promising Rise in Demand

The global Diabetic Retinopathy market size is forecasted to expand at a healthy rate in the coming years. Major investments by industry participants for novel product releases, as well as an increase in mergers and partnerships for expansion strategy, are expected to propel the Diabetic Retinopathy market forward. Globally, the ABC area is likely to lead the market, with the ABC region growing at the quickest CAGR value and providing advantageous prospects for higher revenues.

The top Leading Market Players Covered in this Report are : Novartis, Allergan, Genentech, Bayer AG, Aerpio Pharmaceuticals, BCN Peptides, Ampio Pharmaceuticals, ThromboGenics, Alimera Sciences.

[market-insider]

Diabetic Retinopathy Market 2022 | Anti-VEGF Segment Accounted For The Largest Revenue Share

The global diabetic retinopathy market size is expected to reach USD 13.8 billion by 2030 registering a CAGR of 6.4%, according to a new report by Grand View Research, Inc. The incidence rate of diabetes has been increasing dramatically. According to the International Diabetes Federation, in 2021 there were about 537 million diabetic cases, which is projected to rise to 643 million by 2030 and 783 million by 2045. Diabetes is among the leading cause of blindness in people. Blindness is caused due to leaking or rupturing of retinal blood vessels, which may be permanent or temporary in nature depending on the disease stage. Studies suggest that in 2020 the number of diabetic retinopathy cases were about 103.12 million; the cases are expected to reach 160.5 million by 2045.

Gain deeper insights on the market and receive your free copy with TOC now @: Diabetic Retinopathy Market Report

Rising patient awareness levels and increasing healthcare expenditure are also among the factors which are likely to propel market growth. Moreover, the increasing geriatric population in both developed and developing nations is expected to propel the market over the forecast period. According to the Population Reference Bureau report titled "Aging in the United States”, the number of people in the U.S. aged 65 years and over was projected to increase from around 46 million in 2016 to over 98 million by 2060. Early detection and treatment guidelines for diabetic retinopathy had significantly reduced due to the COVID-19 pandemic-related constraints. When compared to 2019, intravitreal injections for diabetic retinopathy had decreased significantly globally throughout the pandemic, ranging from around 30 to over 100 percent reduction. However, now that the lockdown restrictions have been removed, the market is expected to grow at a significant rate.

[mrfrblogresearch02]

Corneal Transplant Market Report, Growth Insight, Deep Research & Segment Analysis 2027

Market Highlights

Corneal transplant is a surgical procedure performed for the treatment of diseased cornea. Important indications for corneal transplant market are keratoconus, keratitis, and corneal stromal dystrophies. The success rate of the treatment is found to be high, which support the market growth.

Rising prevalence of vision impartment and eye diseases such as diabetic retinopathy in geriatric population and diabetes across the globe drive the global market. Additionally, rising awareness about organ donation and its importance, especially, in the developing countries likely to propel the market growth.

Cost of corneal transplant varies depending upon the region, availability of services, and skilled and qualified professionals. Major difference in the cost is observed, i.e. it is found to be high in the developed countries and low in developing countries still maintaining qualitative care. Therefore, cost effective of the treatment would affect the market growth.

The global corneal transplant market is expected to grow at a CAGR of 10.8% during the forecast period.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4525

Major Players in Corneal Transplant Market:

Some of the key players in the global market are CryoLife, Inc. (U.S.), Exactech, Inc. (U.S.), Köhler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell Corporation (U.S.), Medtronic (U.S.), and Organogenesis Inc. (U.S.).

Regional Analysis

Europe is the largest market for corneal transplant which will exhibit positive growth in the near future due to rising prevalence of diabetes in the European countries and availability of treatment options. According to the World Health Organization, about 60 million Europeans have diabetes and its prevalence is relatively high among people over 25 years.

America is the second leading corneal transplant market across the globe owing to an increasing demand for corneal transplant surgery, and rising prevalence of eye diseases, and vision impairment among people in the U.S.

Asia Pacific market is expected to grow rapidly owing increasing prevalence of chronic diseases such as diabetes, diabetic retinopathy, and obesity. India is one of the international medical tourism destinations across the world, which further exhibits growth opportunities for the corneal transplant market due to availability of cost-effective treatment and rising success rates. Furthermore, the increasing healthcare expenditure by developing countries in Asia Pacific region also contributes to the market growth.

The Middle East & African market is growing steadily owing to rising demand for ophthalmic products and services, and available treatment options.

Segmentation

The global corneal transplant market is segmented on the basis of type, indication, and end user.

On the basis of type, the market is segmented into penetrating keratoplasty, endothelial keratoplasty, descemet stripping automated endothelial keratoplasty (DSAEK), corneal graft, corneal limbal stem cell transplant, and others.

On the basis of indication, the market is segmented into fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others.

On the basis of end user, the market is segmented into hospitals, eye clinics, and others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/corneal-transplant-market-4525

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[leftcomputerpost]

The Global Ophthalmic Lasers Market, which is anticipated to reach a value of US$ 1.3 Billion by 2030.

Technological advancements have deeply penetrated every facet of the healthcare industry, and the ophthalmic lasers market is no exception. Over the years, ophthalmic disorders such as diabetic retinopathy, refractive errors, glaucoma, cataract and age related macular degeneration (AMD) have surged exponentially. This has accelerated demand for advanced surgical procedures.

The introduction of ophthalmic laser surgery has revolutionized ophthalmic care in unprecedented ways. Majority of these technologies are being deployed in cataract surgeries, attributed to the disorder’s widespread prevalence across all continents. Advancements such femtosecond laser surgeries have proven highly instrumental in streamlining ophthalmic procedures, offering lightning speed detection of faulty tissues.

Such reduced detection and treatment timeframes act as major growth catalysts for the global ophthalmic lasers market, which is anticipated to reach a value of US$ 1.3 Bn by 2030.

Ophthalmic Lasers Market- Key Highlights

Ophthalmic lasers market shall expand steadily at a CAGR of 5% from 2020-2030

Cataract surgeries shall account for the majority share of the global ophthalmic lasers market

Femtosecond laser surgery to hold maximum sway throughout the forecast period

North America shall retain market hegemony, owing to increasing regulatory approvals for laser surgeries by authorities

Asia & Europe to contribute nearly identical revenue shares due to rise in surgeries amidst their geriatric population

To remain ‘ahead’ of your competitors, request for a sample

https://www.futuremarketinsights.com/reports/sample/rep-gb-1529

COVID-19 Impact Analysis

The novel coronavirus pandemic will have a significantly high impact on the ophthalmic lasers market. As lockdowns and curbs continue to remain enforced, the number of footfalls across ophthalmology clinics and hospitals have declined considerably. Patient care has diminished by nearly 60%, with only emergency surgeries being permitted.

With in-patient visits becoming next to impossible, ophthalmologists are resorting to telemedicine with regards to consultation and advice to patients. A slump is anticipated in refractive and premium lens surgeries across developing economies in the long-run, attributed to cash crunches experienced by individual households due to the prolonged lockdowns.

At the same time, several countries are enforcing strict social distancing protocols and hygiene practices, keeping demand for ophthalmic laser surgeries sustained. For instance, ophthalmologists in Germany have made it a protocol to test patients requiring intravitreal injections and other procedures for COVID-19. If positive, they are redirected to emergency departments, reducing chances of infection.

“Vendors in the ophthalmic lasers landscape are striving to introduce novel product lines, equipped with multi-frequency selection modes to reduce exposure to intense laser bursts, preventing healthy tissue damage,” infers the FMI analyst.

Competition Dashboard

Prominent vendors in the ophthalmic lasers market include are ZEISS International, Nidek Inc., Bausch & Lomb Inc., Abbot Laboratories Inc., SCHWIND Eye-Tech Solutions, Ziemer Ophthalmic Systems AG, Novartis AG (Alcon), LENSAR LLC., iVIS Technologies and NKT Photonics A/S. New product launches and collaborations have helped these players acquire firm footing.

For in-depth competitive analysis, buy now - Buy Now

https://www.futuremarketinsights.com/checkout/1529

In 2018, ZEISS International rolled out its VISUFIT 1000 digital 3D centration data determination and consultation platform, offering a three-dimensional facial reconstruction which enables ophthalmologists perform precise centration processes on patients.

In July 2020, SCHWIND Eye-Tech acquired CE approval for its SCHWIND ATOS femtosecond laser, permitting eye surgeons to incorporate the technology in their SmartSight refractive surgery procedures.

More Insights on the Ophthalmic Lasers Market

A recent market study published by FMI on the ophthalmic lasers market includes the global industry analysis of 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. The report provides a balanced, unbiased analysis of the overall market scenario based on product type (excimer lasers and femtosecond lasers), application (refractive surgery, cataract surgery, capsulotomy, trabeculoplasty and diagnostics), end-user (hospitals, ophthalmology clinics and ambulatory surgical centers) and region (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).

For booking of appointment -Schedule A Call

https://appoint.ly/s/fmi/introduction

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[industrynewshour]

Vitreoretinal Surgery Device Market Share, Industry Statistics, Trends Evaluation, Business Challenges, Investment Opportunities Analysis to 2027

The global Vitreoretinal surgery device Market is segmented in by surgery type:-anterior vitreoretinal surgery, posterior vitreoretinal surgery; by product:-vitrectomy surgery devices, photocoagulation surgery devices, illumination surgery devices; by end-user:-hospitals, clinics, ambulatory surgical centers and by regions. Vitreoretinal surgery device Market is anticipated to mask a significant CAGR during the forecast period i.e. 2018-2027.

Vitreoretinal Surgery is basically conducted to treat eye complications associated to retina, macula and vitreous fluid.  The complications included for vitreoretinal surgery consists of retinal detachment, uveitis and vitreous hemorrhage, macular degeneration, macular hole, epiretinal membrane or retinal detachment and problems connected to diabetic retinopathy. The various instruments, surgical equipment and tools, designed to assist surgeons perform the surgery come under the aegis of vitreoretinal surgery devices. The global vitreoretinal surgery devices market is estimated to observe a strong growth throughout the forecast period due to growing elderly population, rising frequency of optical ailments and elevating acceptance of automated surgery devices among end users. Escalating number of people deciding for eye surgeries for treatment of visual damage in low and middle revenue countries is also predicted to deliver soaring growth prospects for manufacturers of vitreoretinal surgery devices.

North America is estimated to lead largely the Vitreoretinal surgery devices market over the forecast period. The largest number of ophthalmologists present in U.S.A proves North America to be a lucrative market. Europe follows after North America in Vitreoretinal surgery devices market. Asia-Pacific region is estimated to show healthy growth due to the rising number in patients suffering from diabetic retinoplasty.

Increased R&D activities

Over the previous years, the global market for vitreoretinal surgery devices has observed significant advancements in terms of the effortless accessibility of expert solutions, procedures and instruments, which allow for less intrusive techniques, lower the amount of pain to the eye, and head to decrease curative time and better patient conclusions. Advancements in the market continue at a fast rate and an escalating number of companies are manufacturing extremely hi-tech vitreoretinal surgery devices proficient of aiding the surgery procedure and the total effectiveness of the procedure.

However, even though a vitreoretinal surgery is a comparatively painless procedure with a strong, successful track record in improving vision, the recovery from the surgery is often more challenging because patients must contend with the monotony, stress and discomfort of a 23-hour-a-day facedown-postoperative position which may act as a limit to the growth of global vitreoretinal surgery devices market.

The report titled “Global Vitreoretinal Surgery Device Market: Global Demand Analysis & Opportunity Outlook 2027″ delivers detailed overview of the global Vitreoretinal surgery device market in terms of market segmentation by surgery type:-anterior vitreoretinal surgery, posterior vitreoretinal surgery; by product:-vitrectomy surgery devices, photocoagulation surgery devices, illumination surgery devices; by end-user:-hospitals, clinics, ambulatory surgical centers and by regions.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”  

Download Sample of This Strategic Report:- https://www.researchnester.com/sample-request-909

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

This report also provides the existing competitive scenario of some of the key players of the global Vitreoretinal surgery device market which includes company profiling of Alcon, Inc., Bausch & Lomb Inc., Carl Zeiss Meditec AG, MedOne Surgical, Inc., OCULUS Optikgerate GmbH, Dutch Ophthalmic Research Center International BV, Designs For Vision Pty Ltd, MedOne Surgical, Inc., Nidek Co. Ltd, Peregrine Surgical. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global aerospace fasteners market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.    

Access Full Report? Inquire Here@https://www.researchnester.com/enquiry-send-909      

About Research Nester

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[renubresearchanalysis]

Retinal Surgery Device Market Share, Size , Global Forecast by 2026

Retinal diseases vary widely, but most retinal diseases cause visual symptoms and can affect any part of the retina. The various equipment and accessories used for surgically repairing torn or detached retinas are retinal surgery devices. Worldwide, devices are usually manufactured using stainless steel and medical-grade silicon for better sterility. The common symptoms of retinal diseases are blurred or distorted vision, defects inside vision or lost vision. Globally, Retinal surgeries devices are used to repair retinal torn or detached retinas through laser surgery, cryotherapy. Apart from this, the devices are also used in diabetic retinopathy and other ophthalmic procedures. According to Renub Research, the Global Retinal Surgery Device Market is projected to reach US$ 2.70 Billion by 2027.

Factors Driving the Retinal Surgery Device Industry

Furthermore, globally surging geriatric population, age-related eye disorders, say glaucoma, cataract which can cause loss of vision, is also giving traction to the market growth. More on this, macular degeneration, diabetic retinopathy currently represents the driving force towards this market. Also, worldwide, there is widespread adoption of minimally invasive surgical procedures for the treatment of such diseases, which offer various benefits like minimal pain and discomfort and quick recovery. As per this research report, Worldwide Retinal Surgery Device Market Size was valued at US$ 1.59 Billion in 2020.

Some Facts

As per WHO, by 2050, the world population aged 60 years and older is likely to be 2 billion. The National Diabetes Statistics stated, one often is suffering from diabetes, around 9.4% of the total United States population. Diabetic retinopathy impacts nearly 7.7 million Americans and the number likely to surge to 11.3 million by 2030.

COVID-19 Impact

The COVID-19 pandemic has spread worldwide; millions of people around the globe are infected with COVID-19 disease. Restriction and lockdowns have impacted retinal surgery as most of the medical strength have been assigned to fight the pandemic. But we believe the scenario to improve in future.

By Product

We have covered the Global Retinal Surgery Device market into Vitrectomy Machines, Vitrectomy Packs, Surgical Instruments, Microscopic Illumination Equipment, Retinal Laser Equipment and Others. Vitrectomy Pack is one of the key segments in by product category due to its adoption in the application such as combined retinal surgical procedures, vitreous removal in the mobile retina, epiretinal membrane removal, in posterior vitreous detachment procedures. As per our research analysis, Global Retinal Surgery Device Industry is likely to grow at a CAGR of 7.86% from 2020-2027.

By Application

We have studied the Global Retinal Surgery Device market into Diabetic Retinopathy, Retinal Detachment, Epiretinal Membrane, Macular Hole, and Others. Diabetic Retinopathy dominates the market during the forecast period as it can develop in people suffering from type 1 or type 2 diabetes. Approximately 463 million adults aged 20-79 years were living with diabetes, according to International Diabetes Federation (IDF). And by 2045, these figures would surge to 700 million adults. Also, 79% of adults who have diabetes were from developing nations.

Regional Analysis

We covered the region, North America, Latin America, Europe, Asia Pacific, Middle East & Africa in this report. The North American region holds the dominating position in the global retinal surgery device market. The key players playing a crucial role in the retinal surgery market globally are Topcon Corporation, Alcon AG, Carl Zeiss, Bausch Health Companies Inc and Iridex Corporation.

Renub Research latest report “Retinal Surgery Device Market, Global Forecast by Product (Vitrectomy Machines, Vitrectomy Packs, Surgical Instruments, Microscopic Illumination Equipment, Retinal Laser Equipment and Others), Application (Diabetic Retinopathy, Retinal Detachment, Epiretinal Membrane, Macular Hole, and Others), End Users (Hospitals, Eye Clinics and Others), Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Company Analysis (Topcon Corporation, Alcon AG, Carl Zeiss, Bausch Health Companies Inc and Iridex Corporation)” provides complete details on Global Retinal Surgery Devices Industry.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=retinal-surgery-device-market-global-forecast-p.php

Product –Market breakup from 6 viewpoints

1.    Vitrectomy Machines 2.    Vitrectomy Packs 3.    Surgical Instruments 4.    Microscopic Illumination Equipment 5.    Retinal Laser Equipment 6.    Others

Application – Market breakup from 5 viewpoints

1.    Diabetic Retinopathy 2.    Retinal Detachment 3.    Epiretinal Membrane 4.    Macular Hole 5.    Others

End User – Market breakup from 3 viewpoints

1.    Hospitals 2.    Eye Clinics 3.    Others

Region – Market breakup from 5 viewpoints

1.    North America 2.    Latin America 3.    Europe 4.    Asia Pacific 5.    Middle East & Africa

All Companies have been covered from 3 viewpoints

•    Overview •    Recent Development & Strategies •    Financial Insights

Company Analysis

1.    Topcon Corporation 2.    Alcon AG 3.    Carl Zeiss 4.    Bausch Health Companies Inc 5.    Iridex Corporation

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.

Contact Us: Renub Research Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND) Email: info@renub.com Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research

[market-insights-dbmr]

Global Retinal Biologics Market

Global retinal biologics market is expected to gain market growth at a CAGR of 7.60% in the forecast period of 2020 to 2027. Data Bridge Market Research report on retinal biologics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the market’s growth.

The major players covered in the retinal biologics market are Santen Pharmaceutical Co., Ltd.., Ltd., Regeneron Pharmaceuticals Inc., Shire Plc, AbbVie Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Bayer AG, Novartis AG, Bausch Health Companies Inc.., and Merck & Co., Inc. among others. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Download Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-retinal-biologics-market

The study objectives of this report are:

·         To study and forecast the market size in global Retinal Biologics market.

·         To analyze the global key players, market value, and global market share for top participants of the Retinal Biologics market by employing SWOT analysis.

·         To classify, illustrate, and forecast the market by type, end use, and region.

·         To analyze the market while comparing and forecasting its status between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of the World.

·         To analyze the market potential and advantage, opportunity and challenge, restraints and risks for all the global key regions.

·         To recognize noteworthy trends and factors driving or inhibiting the market growth.

·         To evaluate the market opportunities available for stakeholders by discovering the high growth segments.

·         To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.

·         To study competitive developments such as expansions, new product launches, agreements, and acquisitions in the market.

·         To strategically outline the key players and broadly analyze their growth strategies.

·         To analyze and study the sales, value, status (2021) and forecast (2021-2028) for the global Retinal Biologics market.

·         To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.

·         To examine the key players of the Retinal Biologics market to study the sales, value, market share, and development plans in the future.

 Global Retinal Biologics Market Scope and Market Size

The retinal biologics market is segmented on the basis of diseases indication, end-users and distribution channel. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets.

On the basis of type of diseases indication, the retinal biologics market is segmented into macular degeneration, diabetic retinopathy, retinal vein and occlusion

On the basis of end-users, the retinal biologics market is segmented into hospitals, specialty clinics and others.

On the basis of distribution channel, the retinal biologics market has been segmented into hospital pharmacy, retail pharmacy and others.

Global Retinal Biologics Market Country Level Analysis

Retinal biologics market is analysed and market size information is provided by country, diseases indication, end-users and distribution channel as referenced above.

The countries covered in the retinal biologics market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America has the largest market share as the presence of key manufacturers of the product is high and, increasing research and development activities, healthcare expenditure contributes in raising the significant growth of the market. Asia-Pacific is expected to grow in the over coming years due to increased new research and developments on retinal biologics market.

Enquire Here for, Report Enquiry, Discount and Customization@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-retinal-biologics-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com